Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Dec 5;92(25):11480–11484. doi: 10.1073/pnas.92.25.11480

Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.

X Wang 1, T L Yue 1, F C Barone 1, R F White 1, R K Clark 1, R N Willette 1, A C Sulpizio 1, N V Aiyar 1, R R Ruffolo Jr 1, G Z Feuerstein 1
PMCID: PMC40425  PMID: 8524787

Abstract

Focal brain ischemia is the most common event leading to stroke in humans. To understand the molecular mechanisms associated with brain ischemia, we applied the technique of mRNA differential display and isolated a gene that encodes a recently discovered peptide, adrenomedullin (AM), which is a member of the calcitonin gene-related peptide (CGRP) family. Using the rat focal stroke model of middle cerebral artery occlusion (MCAO), we determined that AM mRNA expression was significantly increased in the ischemic cortex up to 17.4-fold at 3 h post-MCAO (P < 0.05) and 21.7-fold at 6 h post-MCAO (P < 0.05) and remained elevated for up to 15 days (9.6-fold increase; P < 0.05). Immunohistochemical studies localized AM to ischemic neuronal processes, and radioligand (125I-labeled CGRP) displacement revealed high-affinity (IC50 = 80.3 nmol) binding of AM to CGRP receptors in brain cortex. The cerebrovascular function of AM was studied using synthetic AM microinjected onto rat pial vessels using a cranial window or applied to canine basilar arteries in vitro. AM, applied abluminally, produced dose-dependent relaxation of preconstricted pial vessels (P < 0.05). Intracerebroventricular (but not systemic) AM administration at a high dose (8 nmol), prior to and after MCAO, increased the degree of focal ischemic injury (P < 0.05). The ischemia-induced expression of both AM mRNA and peptide in ischemic cortical neurons, the demonstration of the direct vasodilating effects of the peptide on cerebral vessels, and the ability of AM to exacerbate ischemic brain damage suggests that AM plays a significant role in focal ischemic brain injury.

Full text

PDF
11480

Images in this article

11481Fig. 1
on p.11481
11482Fig. 3
on p.11482
11483Fig. 4
on p.11483
11483Fig. 5
on p.11483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amara S. G., Arriza J. L., Leff S. E., Swanson L. W., Evans R. M., Rosenfeld M. G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 1985 Sep 13;229(4718):1094–1097. doi: 10.1126/science.2994212. [DOI] [PubMed] [Google Scholar]
  2. Amara S. G., Jonas V., Rosenfeld M. G., Ong E. S., Evans R. M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982 Jul 15;298(5871):240–244. doi: 10.1038/298240a0. [DOI] [PubMed] [Google Scholar]
  3. Barone F. C., Hillegass L. M., Price W. J., White R. F., Lee E. V., Feuerstein G. Z., Sarau H. M., Clark R. K., Griswold D. E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res. 1991 Jul;29(3):336–345. doi: 10.1002/jnr.490290309. [DOI] [PubMed] [Google Scholar]
  4. Barone F. C., Price W. J., White R. F., Willette R. N., Feuerstein G. Z. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev. 1992 Summer;16(2):219–233. doi: 10.1016/s0149-7634(05)80182-4. [DOI] [PubMed] [Google Scholar]
  5. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Clark R. K., Lee E. V., Fish C. J., White R. F., Price W. J., Jonak Z. L., Feuerstein G. Z., Barone F. C. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull. 1993;31(5):565–572. doi: 10.1016/0361-9230(93)90124-t. [DOI] [PubMed] [Google Scholar]
  8. Cooper G. J. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994 Apr;15(2):163–201. doi: 10.1210/edrv-15-2-163. [DOI] [PubMed] [Google Scholar]
  9. Cooper G. J., Willis A. C., Clark A., Turner R. C., Sim R. B., Reid K. B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8628–8632. doi: 10.1073/pnas.84.23.8628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DeWitt B. J., Cheng D. Y., Caminiti G. N., Nossaman B. D., Coy D. H., Murphy W. A., Kadowitz P. J. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur J Pharmacol. 1994 May 23;257(3):303–306. doi: 10.1016/0014-2999(94)90143-0. [DOI] [PubMed] [Google Scholar]
  11. Gaillard C., Strauss F. Association of poly(CA).poly(TG) DNA fragments into four-stranded complexes bound by HMG1 and 2. Science. 1994 Apr 15;264(5157):433–436. doi: 10.1126/science.8153633. [DOI] [PubMed] [Google Scholar]
  12. Girgis S. I., Macdonald D. W., Stevenson J. C., Bevis P. J., Lynch C., Wimalawansa S. J., Self C. H., Morris H. R., MacIntyre I. Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet. 1985 Jul 6;2(8445):14–16. doi: 10.1016/s0140-6736(85)90059-5. [DOI] [PubMed] [Google Scholar]
  13. Hallenbeck J. M., Dutka A. J., Tanishima T., Kochanek P. M., Kumaroo K. K., Thompson C. B., Obrenovitch T. P., Contreras T. J. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 1986 Mar-Apr;17(2):246–253. doi: 10.1161/01.str.17.2.246. [DOI] [PubMed] [Google Scholar]
  14. Holland J. P., Sydserff S. G., Taylor W. A., Bell B. A. Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia. Stroke. 1994 Oct;25(10):2055–2059. doi: 10.1161/01.str.25.10.2055. [DOI] [PubMed] [Google Scholar]
  15. Ishiyama Y., Kitamura K., Ichiki Y., Nakamura S., Kida O., Kangawa K., Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993 Sep 14;241(2-3):271–273. doi: 10.1016/0014-2999(93)90214-3. [DOI] [PubMed] [Google Scholar]
  16. Jougasaki M., Wei C. M., McKinley L. J., Burnett J. C., Jr Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 1995 Aug 1;92(3):286–289. doi: 10.1161/01.cir.92.3.286. [DOI] [PubMed] [Google Scholar]
  17. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993 Apr 30;192(2):553–560. doi: 10.1006/bbrc.1993.1451. [DOI] [PubMed] [Google Scholar]
  18. Leffert J. D., Newgard C. B., Okamoto H., Milburn J. L., Luskey K. L. Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci U S A. 1989 May;86(9):3127–3130. doi: 10.1073/pnas.86.9.3127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14;257(5072):967–971. doi: 10.1126/science.1354393. [DOI] [PubMed] [Google Scholar]
  20. Liu T., Clark R. K., McDonnell P. C., Young P. R., White R. F., Barone F. C., Feuerstein G. Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994 Jul;25(7):1481–1488. doi: 10.1161/01.str.25.7.1481. [DOI] [PubMed] [Google Scholar]
  21. Liu T., McDonnell P. C., Young P. R., White R. F., Siren A. L., Hallenbeck J. M., Barone F. C., Feurestein G. Z. Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke. 1993 Nov;24(11):1746–1751. doi: 10.1161/01.str.24.11.1746. [DOI] [PubMed] [Google Scholar]
  22. Morris H. R., Panico M., Etienne T., Tippins J., Girgis S. I., MacIntyre I. Isolation and characterization of human calcitonin gene-related peptide. Nature. 1984 Apr 19;308(5961):746–748. doi: 10.1038/308746a0. [DOI] [PubMed] [Google Scholar]
  23. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993 Oct 15;196(1):245–251. doi: 10.1006/bbrc.1993.2241. [DOI] [PubMed] [Google Scholar]
  24. O'Halloran D. J., Bloom S. R. Calcitonin gene related peptide. BMJ. 1991 Mar 30;302(6779):739–740. doi: 10.1136/bmj.302.6779.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993 Sep 15;195(2):921–927. doi: 10.1006/bbrc.1993.2132. [DOI] [PubMed] [Google Scholar]
  26. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986 Aug 29;46(5):659–667. doi: 10.1016/0092-8674(86)90341-7. [DOI] [PubMed] [Google Scholar]
  27. Steenbergh P. H., Höppener J. W., Zandberg J., Lips C. J., Jansz H. S. A second human calcitonin/CGRP gene. FEBS Lett. 1985 Apr 22;183(2):403–407. doi: 10.1016/0014-5793(85)80820-6. [DOI] [PubMed] [Google Scholar]
  28. Wang X., Feuerstein G. Z. Direct sequencing of DNA isolated from mRNA differential display. Biotechniques. 1995 Mar;18(3):448–453. [PubMed] [Google Scholar]
  29. Wang X., Lee G., Liebhaber S. A., Cooke N. E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem. 1992 May 5;267(13):9176–9184. [PubMed] [Google Scholar]
  30. Wang X., Siren A. L., Liu Y., Yue T. L., Barone F. C., Feuerstein G. Z. Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res Mol Brain Res. 1994 Oct;26(1-2):61–68. doi: 10.1016/0169-328x(94)90074-4. [DOI] [PubMed] [Google Scholar]
  31. Wang X., Yue T. L., Young P. R., Barone F. C., Feuerstein G. Z. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab. 1995 Jan;15(1):166–171. doi: 10.1038/jcbfm.1995.18. [DOI] [PubMed] [Google Scholar]
  32. Willette R. N., Sauermelch C. F. Abluminal effects of endothelin in cerebral microvasculature assessed by laser-Doppler flowmetry. Am J Physiol. 1990 Dec;259(6 Pt 2):H1688–H1693. doi: 10.1152/ajpheart.1990.259.6.H1688. [DOI] [PubMed] [Google Scholar]
  33. Willette R. N., Zhang H., Mitchell M. P., Sauermelch C. F., Ohlstein E. H., Sulpizio A. C. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke. 1994 Dec;25(12):2450–2456. doi: 10.1161/01.str.25.12.2450. [DOI] [PubMed] [Google Scholar]
  34. Wilson T., Treisman R. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences. Nature. 1988 Nov 24;336(6197):396–399. doi: 10.1038/336396a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES